Utility of measurable residual disease for predicting treatment outcomes with BCR- and BCL2-Targeted therapies in patients with CLL

William G. Wierda, Thomas J. Kipps, Othman Al-Sawaf, Brenda Chyla, Juliana M.L. Biondo, Yong Mun, Yanwen Jiang, John F. Seymour

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Utility of measurable residual disease for predicting treatment outcomes with BCR- and BCL2-Targeted therapies in patients with CLL'. Together they form a unique fingerprint.

Medicine & Life Sciences